Status:
UNKNOWN
Optimal Prophylactic Method of Venous Thromboembolism (VTE)
Lead Sponsor:
The Catholic University of Korea
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
20-75 years
Phase:
PHASE3
Brief Summary
This study is to define the optimal method of prophylaxis for patients with gastrectomy in Korea and the investigators hypothesized only mechanical method would be enough for preventing VTE on periope...
Detailed Description
Venous thromboembolism (VTE) is common and often fatal complication in patients with cancer. Gastric cancer is the most frequent cancer in Korea. The incidence of VTE would be increased in patients ...
Eligibility Criteria
Inclusion
- Patients diagnosed as gastric cancer
- Elective and curative under general anesthesia
- ECOG score 0-2
- ASA score 3 or less than 3
- Informed consents
Exclusion
- 2nd primary cancer
- VTE history within one year
- Anticoagulation history
- Allergic to heparin
- Pregnancy or expected pregnancy
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
682 Patients enrolled
Trial Details
Trial ID
NCT01448746
Start Date
October 1 2011
End Date
August 1 2017
Last Update
February 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul St. Mary's Hospital
Seoul, South Korea, 137701